Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 23412096)

1.

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES, Fraumeni JF Jr, Curtis RE.

Blood. 2013 Apr 11;121(15):2996-3004. doi: 10.1182/blood-2012-08-448068. Epub 2013 Feb 14.

2.

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.

J Natl Cancer Inst. 2007 Feb 7;99(3):196-205.

3.

Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.

Merlat A, Lai JL, Sterkers Y, Demory JL, Bauters F, Preudhomme C, Fenaux P.

Leukemia. 1999 Feb;13(2):250-7.

PMID:
10025899
4.

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.

Bennett JM, Kaminski MS, Leonard JP, Vose JM, Zelenetz AD, Knox SJ, Horning S, Press OW, Radford JA, Kroll SM, Capizzi RL.

Blood. 2005 Jun 15;105(12):4576-82. Epub 2005 Feb 24.

5.

Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Körbling M, Martin T, Ueno NT, Champlin RE, Khouri IF.

Ann Oncol. 2002 Mar;13(3):450-9.

7.

Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?

Pagano L, Pulsoni A, Tosti ME, Mele A, Mele L, Corvatta L, Miraglia E, Almici C, Manna A, Del Poeta G, Lanza F, Masini L, Recchia A, Equitani F, Leone G, Mandelli F; Italian GIMEMA Group (Gruppo Italiano Malattie Ematologiche dell'Adulto).

Hematol J. 2000;1(5):329-32.

PMID:
11920210
8.

Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients.

Schonfeld SJ, Gilbert ES, Dores GM, Lynch CF, Hodgson DC, Hall P, Storm H, Andersen A, Pukkala E, Holowaty E, Kaijser M, Andersson M, Joensuu H, Fosså SD, Allan JM, Travis LB.

J Natl Cancer Inst. 2006 Feb 1;98(3):215-8.

9.

Risk of second malignant neoplasms among long-term survivors of testicular cancer.

Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Andersson M, Bergfeldt K, Clarke EA, Wiklund T, Stoter G, Gospodarowicz M, Sturgeon J, Fraumeni JF Jr, Boice JD Jr.

J Natl Cancer Inst. 1997 Oct 1;89(19):1429-39.

10.

Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation.

Barnard DR, Lange B, Alonzo TA, Buckley J, Kobrinsky JN, Gold S, Neudorf S, Sanders J, Burden L, Woods WG.

Blood. 2002 Jul 15;100(2):427-34.

11.

Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.

Le Deley MC, Suzan F, Cutuli B, Delaloge S, Shamsaldin A, Linassier C, Clisant S, de Vathaire F, Fenaux P, Hill C.

J Clin Oncol. 2007 Jan 20;25(3):292-300. Epub 2006 Dec 11.

12.

Declining second primary ovarian cancer after first primary breast cancer.

Schonfeld SJ, Berrington de Gonzalez A, Visvanathan K, Pfeiffer RM, Anderson WF.

J Clin Oncol. 2013 Feb 20;31(6):738-43. doi: 10.1200/JCO.2012.43.2757. Epub 2013 Jan 2.

13.
15.

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.

Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, Horwich A, Lister TA, Linch DC.

J Clin Oncol. 2000 Feb;18(3):498-509.

PMID:
10653865
16.

Cancer burden in the HIV-infected population in the United States.

Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA.

J Natl Cancer Inst. 2011 May 4;103(9):753-62. doi: 10.1093/jnci/djr076. Epub 2011 Apr 11.

17.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.

Arch Dermatol. 2007 Jan;143(1):45-50.

PMID:
17224541
19.

Acute leukemia following prolonged cytotoxic agent therapy.

Casciato DA, Scott JL.

Medicine (Baltimore). 1979 Jan;58(1):32-47. Review.

PMID:
105227
20.

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.

Berrington de Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, Ron E.

Br J Cancer. 2010 Jan 5;102(1):220-6. doi: 10.1038/sj.bjc.6605435. Epub 2009 Nov 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk